Seeking ethical designs for HIV clinical trials in treatment-experienced patients: an industry perspective.

Mayers, Douglas L; Chung, Jain; Kohlbrenner, Veronika M; Hall, David B; DeMasi, Ralph A; Neubacher, Dietmar; Buss, Neil E; Salgo, Miklos P

Mayers, Douglas L; Chung, Jain; Kohlbrenner, Veronika M; Hall, David B; DeMasi, Ralph A; Neubacher, Dietmar; Buss, Neil E; Salgo, Miklos P.

Affiliation

Mayers DL; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.

AIDS Res Hum Retroviruses ; 22(11): 1110-2, 2006 Nov.

Article in En | MEDLINE | ID: mdl-17147497

Subject(s)

Anti-HIV Agents/adverse effects; Clinical Trials as Topic/ethics; Drug Industry/ethics; HIV Infections/drug therapy; Research Design; Anti-HIV Agents/therapeutic use; Clinical Trials as Topic/standards; Drug Industry/organization & administration; Humans

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Research Design / HIV Infections / Clinical Trials as Topic / Anti-HIV Agents / Drug Industry Aspects: Ethics Limits: Humans Language: En Journal: AIDS Res Hum Retroviruses Year: 2006 Document type: Article

Search on Google

XML

PubMed Links